Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 22 peer-reviewed journal articles Updated
Pediatrics · CDKL5 Deficiency Disorder

Building Your Care Team and Navigating the Future

At a Glance

Children with CDKL5 deficiency disorder benefit from a coordinated team of specialists. Regular checks for growth, feeding, constipation, vision, bones, and sleep, along with caregiver and school support, help address changing needs over time.

Transitioning from receiving a diagnosis to managing life with CDKL5 Deficiency Disorder (CDD) is a significant shift. Because CDD is a complex, multisystem condition, it cannot be managed by a neurologist alone [1]. Building a dedicated multidisciplinary team—a group of specialists who communicate with each other and with you—is the most important step in navigating the road ahead [2][3].

Your Multidisciplinary Care Team

International consensus guidelines emphasize that care for CDD should be holistic, focusing on the “whole child” rather than just the seizures [1]. Not every family has access to every sub-specialist, but your core team will likely include:

  • Primary Care Pediatrician / Complex Care Clinician: This is the local doctor who manages general health, immunizations, and often coordinates the broader team.
  • Epileptologist or Pediatric Neurologist: This is often the “anchor” of your team. You should look for a specialist who has experience with developmental and epileptic encephalopathies (DEEs) and is familiar with the latest CDD-specific treatments [4][5].
  • Genetic Counselor / Neurogeneticist: These experts help interpret your child’s specific genetic variant and can provide information on recurrence risk and clinical trials [2][6].
  • Gastroenterologist (GI) & Dietitian: Essential for managing severe constipation, reflux, and evaluating the potential need for a feeding tube [7][8].
  • Vision Specialist: Because Cortical Visual Impairment (CVI) is so common, a neuro-ophthalmologist can help assess what your child sees and how to support their visual development [9][10].
  • Rehabilitation Therapists (PT/OT/SLP): Physical, occupational, and speech-language therapists are vital for supporting motor skills, safe transfers, swallowing, and alternative communication [11][12].
  • Developmental Pediatrician: This specialist focuses on the broader picture of your child’s learning, behavior, and social-emotional growth [2].

Measuring Progress: The CCSA

As you begin long-term management, your team may use a specialized tool called the CDKL5 Clinical Severity Assessment (CCSA) [13]. This is a tool used in clinics and research settings to track how the disorder is impacting daily life over time [14].

The CCSA has two complementary parts:

  1. Clinician-Reported: The doctor observes and measures your child’s motor skills, communication, and vision [13].
  2. Caregiver-Reported: You provide detailed information about your child’s seizures, behavior, alertness, and feeding [13][15].

Using a standardized tool like the CCSA helps ensure that your medical team is looking at the same priorities you are and can identify when a treatment is helping or if a new challenge is emerging [13][14]. However, a CCSA score does not replace an individualized clinical examination or shared decision-making with your doctor.

Long-Term Surveillance

Because CDD is a lifelong condition, your child will need regular check-ups to catch and manage issues before they become emergencies [1][2].

Area of Concern Recommended Surveillance
Growth & Nutrition Regular weight, height, and bone health checks; a clinical feeding evaluation to determine if an instrumental study (like VFSS or FEES) is indicated. Aspiration can be “silent” (occurring without coughing or gurgling), so proactive assessment is key [8][16].
Bowel Health Ongoing management of chronic constipation with a gastroenterologist [7].
Orthopedics Regular screenings for scoliosis (curvature of the spine) and hip displacement, dictated by age and mobility status [7][2].
Vision Periodic functional vision assessments to update home and school strategies [9][17].
Sleep Monitoring for changes in sleep patterns or breathing pauses (apneas) [18][19].

Caring for the Caregiver & Navigating Services

The emotional and physical toll of caring for a child with CDD is significant. Studies show that caregivers face high levels of sleep deprivation, financial strain, and chronic stress [20][19][21]. It is not a sign of weakness to ask for help; it is a clinical necessity for your child’s well-being [18].

Early intervention should be “family-centered,” meaning the goal is to support the health of the entire family unit [1]. This may include seeking out:

  • Education and Transition: Working with your school district for a strong Individualized Education Program (IEP). As your child grows, transition planning for adult services and guardianship is crucial.
  • Respite Care: Scheduled breaks to rest and recharge.
  • Social Work: Help navigating insurance, school services, and government support.
  • Patient Advocacy Groups: Connecting with other CDD families can reduce isolation and provide invaluable practical tips [6][22].

Navigating the future with CDD requires patience and a strong support network. While the journey is long, a proactive and organized care team can help you focus on what matters most: your child’s comfort, happiness, and continued progress.

Common questions in this guide

What specialists should be on my child’s CDKL5 deficiency disorder care team?
Care often involves a primary care or complex-care clinician, a pediatric neurologist or epileptologist, a genetic counselor, a gastroenterologist and dietitian, a vision specialist, rehabilitation therapists, and a developmental pediatrician. The exact team depends on your child’s needs and local access. The specialists should communicate with one another and with your family.
How does the CCSA track progress in CDKL5 deficiency disorder?
The CDKL5 Clinical Severity Assessment is a standardized tool used in clinics and research to follow how CDD affects daily life over time. Clinicians assess areas such as movement, communication, and vision, while caregivers report seizures, behavior, alertness, and feeding. It supports conversations about care but does not replace an examination or shared decisions with the treating team.
What regular health checks does a child with CDD need?
Monitoring commonly includes growth, nutrition, feeding and swallowing, bone health, bowel function, vision, and sleep or breathing. Clinicians may screen for silent aspiration, scoliosis, and hip displacement based on age and mobility. The schedule should be individualized with your child’s care team.
How can we support caregiver health while managing CDD?
Family-centered care can include respite, social work, school support, transition planning, and patient advocacy groups. Caregivers should seek help for sleep deprivation, stress, financial strain, or isolation; support for caregiver well-being helps the whole family.
How do I choose a neurologist for a child with CDD?
Ask about experience with CDD and other developmental and epileptic encephalopathies, familiarity with CDD-specific treatments such as ganaxolone, communication with other specialists, and after-hours access. A neurologist who can coordinate with the broader team can help address seizures and other aspects of CDD.
What information should we track between CDD appointments?
Families may track seizures, feeding, bowel habits, sleep and breathing, alertness, behavior, therapies, appointments, and test results. An app or binder can make patterns easier to share with clinicians and can help the team see whether goals are improving.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.How much experience do you have managing CDD or other developmental and epileptic encephalopathies (DEEs)?
  2. 2.Are you comfortable prescribing and monitoring CDD-specific treatments like ganaxolone?
  3. 3.How do you coordinate care with the other specialists (GI, vision, therapy) my child needs?
  4. 4.Do you use standardized tools like the CDKL5 Clinical Severity Assessment (CCSA) to track my child's progress over time?
  5. 5.What is the process for reaching your team after hours or if we have questions about medication side effects?
  6. 6.Are there social workers or patient navigators in your clinic who can help us access respite care or financial support?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (22)
  1. 1

    International Consensus Recommendations for the Assessment and Management of Individuals With CDKL5 Deficiency Disorder.

    Amin S, Monaghan M, Aledo-Serrano A, et al.

    Frontiers in neurology 2022; (13()):874695 doi:10.3389/fneur.2022.874695.

    PMID: 35795799
  2. 2

    Providing quality care for people with CDKL5 deficiency disorder: A European expert panel opinion on the patient journey.

    Amin S, Møller RS, Aledo-Serrano A, et al.

    Epilepsia open 2024; (9(3)):832-849 doi:10.1002/epi4.12914.

    PMID: 38450883
  3. 3

    Exploring neurodevelopment in CDKL5 deficiency disorder: Current insights and future directions.

    Dell'Isola GB, Perinelli MG, Frulli A, et al.

    Epilepsy & behavior : E&B 2025; (171()):110504 doi:10.1016/j.yebeh.2025.110504.

    PMID: 40414190
  4. 4

    Ganaxolone: A Review in Epileptic Seizures Associated with Cyclin-Dependent Kinase-Like 5 Deficiency Disorder.

    Hoy SM

    Paediatric drugs 2025; (27(1)):111-118 doi:10.1007/s40272-024-00670-6.

    PMID: 39792341
  5. 5

    Epileptic spasms in CDKL5 deficiency disorder: Delayed treatment and poor response to first-line therapies.

    Olson HE, Demarest S, Pestana-Knight E, et al.

    Epilepsia 2023; (64(7)):1821-1832 doi:10.1111/epi.17630.

    PMID: 37114835
  6. 6

    The small steps that lead to big impact: translating therapeutics from idea to reality for the CDKL5 deficiency disorder community.

    Jaksha A, Bishop M, Utley K, Grabenstatter HL

    Therapeutic advances in rare disease 2024; (5()):26330040241275673 doi:10.1177/26330040241275673.

    PMID: 39247150
  7. 7

    The natural history of CDKL5 deficiency disorder into adulthood.

    Aledo-Serrano A, Lewis-Smith D, Leonard H, et al.

    medRxiv : the preprint server for health sciences 2025; doi:10.1101/2025.01.12.24318239.

    PMID: 39867409
  8. 8

    Growth patterns in individuals with CDKL5 deficiency disorder.

    Wong K, Davies G, Leonard H, et al.

    Developmental medicine and child neurology 2024; (66(4)):469-482 doi:10.1111/dmcn.15777.

    PMID: 37804112
  9. 9

    Cerebral Visual Impairment in CDKL5 Deficiency Disorder Correlates With Developmental Achievement.

    Brock D, Fidell A, Thomas J, et al.

    Journal of child neurology 2021; (36(11)):974-980 doi:10.1177/08830738211019284.

    PMID: 34547934
  10. 10

    Cerebral visual impairment in CDKL5 deficiency disorder: vision as an outcome measure.

    Olson HE, Costantini JG, Swanson LC, et al.

    Developmental medicine and child neurology 2021; (63(11)):1308-1315 doi:10.1111/dmcn.14908.

    PMID: 34028805
  11. 11

    Communication of individuals with CDKL5 deficiency disorder as observed by caregivers: A descriptive qualitative study.

    Keeley J, Benson-Goldberg S, Saldaris J, et al.

    American journal of medical genetics. Part A 2024; (194(7)):e63570 doi:10.1002/ajmg.a.63570.

    PMID: 38425131
  12. 12

    Factors influencing the attainment of major motor milestones in CDKL5 deficiency disorder.

    Wong K, Junaid M, Demarest S, et al.

    European journal of human genetics : EJHG 2023; (31(2)):169-178 doi:10.1038/s41431-022-01163-1.

    PMID: 35978140
  13. 13

    Psychometric evaluation of clinician- and caregiver-reported clinical severity assessments for individuals with CDKL5 deficiency disorder.

    Saldaris JM, Jacoby P, Downs J, et al.

    Epilepsia 2024; (65(10)):3064-3075 doi:10.1111/epi.18094.

    PMID: 39190322
  14. 14

    Beyond Seizures as an Outcome Measure: A Global Severity Scoring System for CDKL5 Deficiency Disorder.

    Jacoby P, Marsh ED, Demarest S, et al.

    Brain and behavior 2025; (15(11)):e71061 doi:10.1002/brb3.71061.

    PMID: 41235743
  15. 15

    The development, content and response process validation of a caregiver-reported severity measure for CDKL5 deficiency disorder.

    Ziniel SI, Mackie A, Saldaris J, et al.

    Epilepsy research 2023; (197()):107231 doi:10.1016/j.eplepsyres.2023.107231.

    PMID: 37751639
  16. 16

    Pneumonitis and pneumonia after aspiration.

    Son YG, Shin J, Ryu HG

    Journal of dental anesthesia and pain medicine 2017; (17(1)):1-12 doi:10.17245/jdapm.2017.17.1.1.

    PMID: 28879323
  17. 17

    Initial Validation and Reliability of the CDKL5 Deficiency Disorder Hand Function Scale (CDD-Hand).

    Saldaris J, Leonard H, Jacoby P, et al.

    Journal of child neurology 2022; (37(6)):541-547 doi:10.1177/08830738221091044.

    PMID: 35422141
  18. 18

    Long time polysomnographic sleep and breathing evaluations in children with CDKL5 deficiency disorder.

    Hagebeuk EEO, Smits A, de Weerd A

    Sleep medicine 2023; (103()):173-179 doi:10.1016/j.sleep.2023.02.003.

    PMID: 36812861
  19. 19

    Exploring sleep challenges in CDKL5 Deficiency Disorder.

    Leonard H, Szepe E, Junaid M, et al.

    Journal of neurodevelopmental disorders 2026; (18(1)).

    PMID: 41484992
  20. 20

    Caregivers' Perceptions of Clinical Symptoms, Disease Management, and Quality of Life Impact in Cases of Cyclin-Dependent Kinase-Like 5 Deficiency Disorder: Cross-Sectional Online Survey.

    Amin S, Partridge CA, Leonard H, et al.

    JMIR formative research 2025; (9()):e72489 doi:10.2196/72489.

    PMID: 40493384
  21. 21

    Exploring quality of life in individuals with a severe developmental and epileptic encephalopathy, CDKL5 Deficiency Disorder.

    Leonard H, Junaid M, Wong K, et al.

    Epilepsy research 2021; (169()):106521 doi:10.1016/j.eplepsyres.2020.106521.

    PMID: 33341033
  22. 22

    Rescue Medications in Epilepsy Patients: A Family Perspective.

    Gaínza-Lein M, Benjamin R, Stredny C, et al.

    Seizure 2017; (52()):188-194 doi:10.1016/j.seizure.2017.10.007.

    PMID: 29055868

This page offers general information about organizing care for a child with CDKL5 deficiency disorder and does not constitute medical advice. Your child’s clinicians should tailor surveillance, treatments, therapies, and support services to their needs.

Get notified when new evidence is published on CDKL5-deficiency disorder.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.